Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
Examines whether works created using generative AI meet India’s legal standards of originality and authorship under existing copyright ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback